The National Health Research Ethics Committee, Nigeria, has approved the use of
an experimental Ebola drug, Zmapp, for treatment of patients infected with the virus.
The decision by the committee is coming on the heels of yesterday’s approval by the
World Health Organisation (WHO) on the use of Zmapp for treatment of Ebola patients.
No comments:
Post a Comment